Invesco Ltd. Rx Sight, Inc. Transaction History

Invesco Ltd.

$600 Billion
Q3 2025

A detailed history of Invesco Ltd. transactions in Rx Sight, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 18,865 shares of RXST stock, worth $183,556. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,865

Previous 20,083 6.06%

Holding current value

$183,556

Previous $261,000 35.25%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$6.65 - $13.14 $8,099 - $16,004	-1,218 Reduced 6.06%	18,865 $169,000
Q2 2025 Aug 13, 2025	BUY	$13.0 - $26.12 $1,040 - $2,089	80 Added 0.4%	20,083 $261,000
Q1 2025 May 12, 2025	SELL	$24.37 - $35.84 $9.05 Million - $13.3 Million	-371,160 Reduced 94.89%	20,003 $505,000
Q4 2024 Feb 13, 2025	SELL	$33.66 - $54.73 $20.1 Million - $32.6 Million	-596,434 Reduced 60.39%	391,163 $13.4 Million
Q3 2024 Nov 12, 2024	SELL	$40.78 - $57.04 $2.72 Million - $3.8 Million	-66,586 Reduced 6.32%	987,597 $48.8 Million

Q2 2024 Aug 13, 2024	BUY	$50.42 - $64.29 $14.4 Million - $18.3 Million	285,228 Added 37.09%	1,054,183 $63.4 Million
Q1 2024 May 14, 2024	BUY	$35.51 - $57.92 $18.6 Million - $30.4 Million	525,138 Added 215.38%	768,955 $39.7 Million
Q4 2023 Feb 12, 2024	BUY	$20.91 - $40.9 $2.41 Million - $4.72 Million	115,466 Added 89.96%	243,817 $9.83 Million
Q3 2023 Nov 13, 2023	SELL	$27.05 - $33.37 $1.09 Million - $1.35 Million	-40,372 Reduced 23.93%	128,351 $3.58 Million
Q2 2023 Aug 11, 2023	BUY	$16.37 - $28.9 $586,438 - $1.04 Million	35,824 Added 26.96%	168,723 $4.86 Million
Q1 2023 May 12, 2023	BUY	$12.58 - $16.68 $1.67 Million - $2.22 Million	132,899 New	132,899 $2.22 Million

Others Institutions Holding RXST

# of Institutions

168

Shares Held

32.2M

Call Options Held

64.6K

Put Options Held

62.9K

View Full List

About RxSight, Inc.

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $269M
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

More about RXST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account